Adenosine is an endogenous purine nucleoside, marketed in an injectable form (Adenocor – Sanofi Winthrop) for the treatment of junctional tachycardia (supraventricular tachycardia involving atrioventricular re-entry circuits), and for the diagnosis of broad or narrow complex tachycardias. In this article we discuss its use and consider how it compares with conventional treatment using verapamil.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.